Interpace Biosciences Inc Encaminhar P/E
Qual é o Encaminhar P/E de Interpace Biosciences Inc?
O Encaminhar P/E de Interpace Biosciences Inc é -0.76
Qual é a definição de Encaminhar P/E?
A razão entre preço e lucro a termo é a razão entre o preço das ações da empresa e o lucro estimado por ação da empresa para os próximos doze meses.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Encaminhar P/E de empresas na Setor Health Care em NASDAQ em comparação com Interpace Biosciences Inc
O que Interpace Biosciences Inc faz?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas com encaminhar p/e semelhantes a Interpace Biosciences Inc
- Neuronetics Inc tem Encaminhar P/E de -0.79
- Cara Therapeutics Inc tem Encaminhar P/E de -0.78
- Magenta Therapeutics Inc tem Encaminhar P/E de -0.78
- Dynatronics tem Encaminhar P/E de -0.78
- Onconova Therapeutics Inc tem Encaminhar P/E de -0.78
- Energous Corp tem Encaminhar P/E de -0.77
- Interpace Biosciences Inc tem Encaminhar P/E de -0.76
- Milestone Pharmaceuticals Inc tem Encaminhar P/E de -0.76
- Sonnet BioTherapeutics Inc tem Encaminhar P/E de -0.75
- Aspen Inc tem Encaminhar P/E de -0.75
- Aclaris Therapeutics Inc tem Encaminhar P/E de -0.74
- MusclePharm tem Encaminhar P/E de -0.74
- Karyopharm Therapeutics Inc tem Encaminhar P/E de -0.73